Health and Me

Tanya Dutt

Hepatitis A To E: How Each Virus Affects Your Liver?

The liver doesn’t ask for much, but it does everything for you. It metabolizes nutrients, screens out poisons, synthesizes proteins, and aids in the digestion of your food. But when <span><a href="https://www.healthandme.com/health/hepatitis">hepatitis</a></span> strikes—a disease characterized by swelling of the liver—that whole system can become unbalanced. And the most likely culprits? The five viruses simply called hepatitis A, B, C, D, and E.

Each viral hepatitis type acts differently, transmits itself differently, and does its own kind of damage. Some resolve rapidly. Others lie dormant for years, silently harming the liver until it is too late. This makes learning about hepatitis—not as a disease but as a category of very different conditions—key to safeguarding long-term liver health.

When your liver becomes inflamed, it has difficulty doing its vital jobs—purifying your blood, making bile for digestion, storing nutrients, and helping to regulate clotting and metabolism. This inflammation may be acute (temporary) or chronic (longer than six months), depending on the cause and how your immune system reacts.

Hepatitis may be initiated by infections, toxins, autoimmune, or metabolic disorders, but the predominant offenders worldwide are viral infections. The viruses are segregated into hepatitis A through E, each with a different effect on liver cells and course of disease.

Hepatitis A is caused by the hepatitis A virus (HAV), usually spreading by food or water contamination. After entering the body, the virus takes the route of the bloodstream and reaches the liver. There, it infects liver cells and triggers the immune system to respond with inflammation.

This immune response results in the death of infected liver cells, and this can cause symptoms such as fatigue, jaundice, and gastrointestinal disturbance. Happily, HAV does not lead to chronic liver disease. The liver will normally regenerate completely after clearing the virus, and the majority of individuals recover in several weeks with no long-term effects.

All that being said, on occasion—most often in older individuals or individuals with existing liver disease—hepatitis A can result in acute liver failure. The liver gets so bogged down from inflammation that it temporarily ceases to function. Vaccination and proper sanitation are still the best defense.

Hepatitis B virus (HBV) is spread through blood, body fluids, or from mother to child at the time of birth. After entering the body, HBV infects liver cells and embeds its genetic material into them. The immune system destroys these infected cells, leading to extensive inflammation.

In most adults, the immune system eliminates the virus and the liver recovers. But not in all—particularly infants infected at birth—the virus persists. Chronic hepatitis B forms when the body's immune system fails to destroy the virus, resulting in prolonged inflammation and eventual loss of liver cells.

With time, this persistent immune attack can result in fibrosis (liver scarring), cirrhosis (severe, permanent scarring), and even liver cancer. What's particularly alarming is that chronic hepatitis B usually has no symptoms for decades. But below the radar, the virus quietly destroys liver tissue, cell by cell.

Vaccination prevents hepatitis B remarkably well, and antiviral medications can suppress the virus, stopping or slowing liver damage.

In contrast to HAV and HBV, hepatitis C virus (HCV) is transmitted nearly exclusively via the blood—usually through shared needles, untested transfusions (prior to 1992), or unsterilized medical procedures. Once infected by HCV, the liver starts to replicate the virus within liver cells, hiding from the immune system for years.

This sneaky virus hardly ever produces symptoms at the acute stage. Actually, most individuals don't even realize they are infected. But the liver doesn't remain unaffected. As HCV quietly multiplies, it causes low-grade inflammation that lasts for decades. The immune system acts against the infected cells, causing fibrosis.

Over time, chronic hepatitis C can lead to cirrhosis, in which scar tissue forms in place of healthy liver tissue. In later stages, the function of the liver declines, and the risk of liver failure and liver cancer accelerates. A liver transplant becomes the only recourse for many.

The better news? Direct-acting antiviral (DAA) treatments now cure greater than 95% of infections. Early diagnosis, however, is still important—once cirrhosis takes hold, the damage can be permanent, even once the virus is gone.

Hepatitis D, or HDV, is different from the others—it can't infect the liver by itself. It only exists in those already infected with hepatitis B, employing the outer shell of the HBV virus to replicate.

When HBV and HDV infect the liver concurrently (a co-infection) or if HDV is contracted later on superimposition of pre-existing HBV (a superinfection), the immune system is twice assaulted. The liver has to cope with more intense inflammation, resulting in more rapid fibrosis progression and much increased risk of cirrhosis and hepatocellular carcinoma.

In individuals with co-infection, liver injury is more severe, and complications arise years sooner than in HBV mono-infection. There are no specific therapies for HDV currently, and its management relies mostly on the control of hepatitis B.

It is also possible to prevent HBV infection and thereby hepatitis D by vaccination. Antiviral therapy and close follow-up can likewise decrease the chances of serious HDV complications in those already infected with HBV.

Hepatitis E virus (HEV) is transmitted primarily through water, which makes it prevalent in underdeveloped countries with inadequate sanitation. Upon entry into the body, it acts like HAV—producing an acute infection, <span>liver inflammation</span>, and a short duration of illness.

The vast majority of healthy individuals with hepatitis E recover uneventfully. The virus is naturally cleared, and the liver generally restores to normal completely. But in pregnant women, particularly in the third trimester, hepatitis E leads to acute liver failure and has a significantly increased risk of death. This is secondary to an overactive immune response and hormonal changes that exacerbate the liver's inflammatory process.

Hepatitis E can, in rare cases, become chronic, leading to long-term damage of the liver in some individuals, such as organ transplant recipients, especially those with weakened immune systems.

Prevention through clean water, sanitation, and hygiene and food safety is practiced in most countries where there are no widely available vaccines for hepatitis E.

<h2>What Are the Consequences of Chronic Hepatitis?</h2>

What links hepatitis B, C, and occasionally D is that they all have the potential to become chronic—i.e., the virus continues to cause liver inflammation over years or even decades. This ongoing low-grade inflammation leads to persistent scarring of liver tissue, called fibrosis.

As fibrosis progresses, it results in cirrhosis, with scar tissue dominating the liver, strangling its blood supply and function. The liver starts to fail. It is no longer able to process toxins, manufacture clotting factors, or metabolize drugs. Here, individuals are susceptible to internal bleeding, confusion, infections, and organ failure.

Even more concerning is the risk of hepatocellular carcinoma, a liver cancer primary to chronic hepatitis B and C. The chronic viral presence causes changes in DNA of liver cells, paving the way for malignant change.

<h2>What If Hepatitis Is Left Untreated?</h2>

Not treating hepatitis—especially the chronic stages—places you on a trajectory for irreversible liver damage. Even when you may not be feeling sick at present, inflammation can be quietly devouring your liver. Left untreated, this can culminate in lifelong disability, necessitate liver transplantation, or cut short lifespan from complications such as liver cancer.

In addition, untreated individuals can go on to infect others with hepatitis B or C by contact with blood or through sex. In pregnant women, hepatitis B and C can be transmitted to the unborn child at the time of delivery, which makes prevention and early treatment critical to the next generation.

Every year on July 28, World Hepatitis Day calls to mind that hepatitis remains a global health issue. More than 354 million individuals have chronic hepatitis B or C infection, unaware they are infected. It's not only an issue in low-income nations—people from all geographies and income groups are affected by hepatitis.

The date commemorates Nobel laureate scientist Dr. Baruch Blumberg, who discovered the hepatitis B virus and created the first vaccine. His legacy goes on saving millions of lives.

The World Health Organization's goal is ambitious, to eradicate viral hepatitis as a public health threat by 2030. But it begins with awareness, testing, vaccination, and access to life-saving treatment.

The liver is tough, but not forever. Once scarring sets in, there is no turning back. The sooner hepatitis is found, the better your chances of recovery and preventing long-term complications. With vaccines to prevent hepatitis A and B, and curative therapy for hepatitis C, the means are at hand.

If you’ve never been tested for hepatitis, especially if you’ve had a blood transfusion before the 90s, were born to an infected mother, or engaged in high-risk behaviors now is the time. Your liver’s future depends on it.

Health Conditions A-Z

health

hepatitis

hepatitis a to e

liver inflammation

hepatitis symptoms

hepatitis diagnosis

hepatitis treatment

viral hepatitis types

hepatitis prevention

Non-Alcoholic Fatty Liver

Children's Health Has Declined Significantly In The Past Decade - What Caused This And Can It Improve?

Think You Cannot Grow Brain Cells In Adulthood? These 7 Foods Say Otherwise, According to a Harvard Doctor

New Sweat-Sensing Wearable Could Help Monitor And Improve Bipolar Disorder Treatment

Health & Wellness

Yoga Prop Essentials To Improve Your Exercise Session

Should Potatoes Be The Part Of A Healthy Diet?

Best And Worst Foods To Lower Blood Pressure

Low-Impact Cardio Workouts You Should Try

10 Healthy Pasta Salad Dressing For Weight Loss

Breathing Exercise You Should Do To Relieve Stress

Headache vs. Migraine: Difference Explained In 60 Seconds

High Carb Foods That Are Actually Healthy

How Many Times Do You Need To Wash Your Face?

Hypothyroidism Diet – What To Eat And What You Should Avoid

Stretches To Relieve Leg Pain And Numbness After Sitting For Too Long

No-Cook Healthy Meals For Lazy Days At Home

Easy Breakfast Options To Try During Calorie Deficit

How To Stop Muscle Cramps Immediately

Why You Should Go For An Anti-Inflammatory Diet

Foods To Lower Cortisol Levels In Your Body

High-Fiber Dips You Can Make At Home For The Week

Weekend Warrior Exercises To Makeup For Stressful Week

Experiencing Headaches At Word? Natural Remedies To Try

Yoga Poses That Enhance Digestion

Health Benefits of Walking Backwards

No Eggs? Egg-Alternatives You Can Add To Your Diet

Savory And Smart Ways To Add Broccoli To Your Diet

Calorie Burning Habits That Can Help You Shed Extra Pounds

Yoga Poses That Can Help With Bloating

Fiber-Rich Oatmeal Dishes You Can Have For Breakfast

Signs You Must Visit A Doctor For Your Back Pain

Avocado Meal Prep Ideas To Increase Healthy Fat In Your Diet

Arm Exercises You Can Do At Home

Quick-Office Lunches That Can Keep You Full-Longer

How Increased Screen Time Affects Children's Health

Homemade Recipe To Make Protein-Rich Pancakes With Healthy Alternatives

Push-Up Variations You Can Do At Home

Common Mistakes Running Mistakes People Make

Low-Calorie Foods That Keep You Full For Long

Yoga Poses That Help You Get Rid Of Back Pain

Natural Ways To Increase Protein In Your Diet

Managing Excessive Daytime Sleepiness – Tips To Try

How Much Protein Is Too Much?

High Fiber Indian Foods You Should Try

The liver doesn’t ask for much, but it does everything for you. It metabolizes nutrients, screens out poisons, synthesizes proteins, and aids in the digestion of your food. But when hepatitis strikes—a disease characterized by swelling of the liver—that whole system can become unbalanced. And the most likely culprits? The five viruses simply called hepatitis A, B, C, D, and E.Each viral hepatitis type acts differently, transmits itself differently, and does its own kind of damage. Some resolve rapidly. Others lie dormant for years, silently harming the liver until it is too late. This makes learning about hepatitis—not as a disease but as a category of very different conditions—key to safeguarding long-term liver health.When your liver becomes inflamed, it has difficulty doing its vital jobs—purifying your blood, making bile for digestion, storing nutrients, and helping to regulate clotting and metabolism. This inflammation may be acute (temporary) or chronic (longer than six months), depending on the cause and how your immune system reacts.Hepatitis may be initiated by infections, toxins, autoimmune, or metabolic disorders, but the predominant offenders worldwide are viral infections. The viruses are segregated into hepatitis A through E, each with a different effect on liver cells and course of disease.Hepatitis AHepatitis A is caused by the hepatitis A virus (HAV), usually spreading by food or water contamination. After entering the body, the virus takes the route of the bloodstream and reaches the liver. There, it infects liver cells and triggers the immune system to respond with inflammation.This immune response results in the death of infected liver cells, and this can cause symptoms such as fatigue, jaundice, and gastrointestinal disturbance. Happily, HAV does not lead to chronic liver disease. The liver will normally regenerate completely after clearing the virus, and the majority of individuals recover in several weeks with no long-term effects.All that being said, on occasion—most often in older individuals or individuals with existing liver disease—hepatitis A can result in acute liver failure. The liver gets so bogged down from inflammation that it temporarily ceases to function. Vaccination and proper sanitation are still the best defense.Hepatitis BHepatitis B virus (HBV) is spread through blood, body fluids, or from mother to child at the time of birth. After entering the body, HBV infects liver cells and embeds its genetic material into them. The immune system destroys these infected cells, leading to extensive inflammation.In most adults, the immune system eliminates the virus and the liver recovers. But not in all—particularly infants infected at birth—the virus persists. Chronic hepatitis B forms when the body's immune system fails to destroy the virus, resulting in prolonged inflammation and eventual loss of liver cells.With time, this persistent immune attack can result in fibrosis (liver scarring), cirrhosis (severe, permanent scarring), and even liver cancer. What's particularly alarming is that chronic hepatitis B usually has no symptoms for decades. But below the radar, the virus quietly destroys liver tissue, cell by cell.Vaccination prevents hepatitis B remarkably well, and antiviral medications can suppress the virus, stopping or slowing liver damage.Hepatitis CIn contrast to HAV and HBV, hepatitis C virus (HCV) is transmitted nearly exclusively via the blood—usually through shared needles, untested transfusions (prior to 1992), or unsterilized medical procedures. Once infected by HCV, the liver starts to replicate the virus within liver cells, hiding from the immune system for years.This sneaky virus hardly ever produces symptoms at the acute stage. Actually, most individuals don't even realize they are infected. But the liver doesn't remain unaffected. As HCV quietly multiplies, it causes low-grade inflammation that lasts for decades. The immune system acts against the infected cells, causing fibrosis.Over time, chronic hepatitis C can lead to cirrhosis, in which scar tissue forms in place of healthy liver tissue. In later stages, the function of the liver declines, and the risk of liver failure and liver cancer accelerates. A liver transplant becomes the only recourse for many.The better news? Direct-acting antiviral (DAA) treatments now cure greater than 95% of infections. Early diagnosis, however, is still important—once cirrhosis takes hold, the damage can be permanent, even once the virus is gone.Hepatitis DHepatitis D, or HDV, is different from the others—it can't infect the liver by itself. It only exists in those already infected with hepatitis B, employing the outer shell of the HBV virus to replicate.When HBV and HDV infect the liver concurrently (a co-infection) or if HDV is contracted later on superimposition of pre-existing HBV (a superinfection), the immune system is twice assaulted. The liver has to cope with more intense inflammation, resulting in more rapid fibrosis progression and much increased risk of cirrhosis and hepatocellular carcinoma.In individuals with co-infection, liver injury is more severe, and complications arise years sooner than in HBV mono-infection. There are no specific therapies for HDV currently, and its management relies mostly on the control of hepatitis B.It is also possible to prevent HBV infection and thereby hepatitis D by vaccination. Antiviral therapy and close follow-up can likewise decrease the chances of serious HDV complications in those already infected with HBV.Hepatitis EHepatitis E virus (HEV) is transmitted primarily through water, which makes it prevalent in underdeveloped countries with inadequate sanitation. Upon entry into the body, it acts like HAV—producing an acute infection, liver inflammation, and a short duration of illness.The vast majority of healthy individuals with hepatitis E recover uneventfully. The virus is naturally cleared, and the liver generally restores to normal completely. But in pregnant women, particularly in the third trimester, hepatitis E leads to acute liver failure and has a significantly increased risk of death. This is secondary to an overactive immune response and hormonal changes that exacerbate the liver's inflammatory process.Hepatitis E can, in rare cases, become chronic, leading to long-term damage of the liver in some individuals, such as organ transplant recipients, especially those with weakened immune systems.Prevention through clean water, sanitation, and hygiene and food safety is practiced in most countries where there are no widely available vaccines for hepatitis E.What Are the Consequences of Chronic Hepatitis?What links hepatitis B, C, and occasionally D is that they all have the potential to become chronic—i.e., the virus continues to cause liver inflammation over years or even decades. This ongoing low-grade inflammation leads to persistent scarring of liver tissue, called fibrosis.As fibrosis progresses, it results in cirrhosis, with scar tissue dominating the liver, strangling its blood supply and function. The liver starts to fail. It is no longer able to process toxins, manufacture clotting factors, or metabolize drugs. Here, individuals are susceptible to internal bleeding, confusion, infections, and organ failure.Even more concerning is the risk of hepatocellular carcinoma, a liver cancer primary to chronic hepatitis B and C. The chronic viral presence causes changes in DNA of liver cells, paving the way for malignant change.What If Hepatitis Is Left Untreated?Not treating hepatitis—especially the chronic stages—places you on a trajectory for irreversible liver damage. Even when you may not be feeling sick at present, inflammation can be quietly devouring your liver. Left untreated, this can culminate in lifelong disability, necessitate liver transplantation, or cut short lifespan from complications such as liver cancer.In addition, untreated individuals can go on to infect others with hepatitis B or C by contact with blood or through sex. In pregnant women, hepatitis B and C can be transmitted to the unborn child at the time of delivery, which makes prevention and early treatment critical to the next generation.Every year on July 28, World Hepatitis Day calls to mind that hepatitis remains a global health issue. More than 354 million individuals have chronic hepatitis B or C infection, unaware they are infected. It's not only an issue in low-income nations—people from all geographies and income groups are affected by hepatitis.The date commemorates Nobel laureate scientist Dr. Baruch Blumberg, who discovered the hepatitis B virus and created the first vaccine. His legacy goes on saving millions of lives.The World Health Organization's goal is ambitious, to eradicate viral hepatitis as a public health threat by 2030. But it begins with awareness, testing, vaccination, and access to life-saving treatment.The liver is tough, but not forever. Once scarring sets in, there is no turning back. The sooner hepatitis is found, the better your chances of recovery and preventing long-term complications. With vaccines to prevent hepatitis A and B, and curative therapy for hepatitis C, the means are at hand.If you’ve never been tested for hepatitis, especially if you’ve had a blood transfusion before the 90s, were born to an infected mother, or engaged in high-risk behaviors now is the time. Your liver’s future depends on it.

hepatitis a to e: how each virus affects your liver?

Aarushi Bhadury

US Fertility Rate Crawled To A Record Low In 2024, CDC Confirms; Should We Be Alarmed?

us fertility rate crawled to a record low in 2024, cdc confirms; should we be alarmed?

Grieving The Loss Of A Loved One Too Intensely Can Double The Risk Of Early Death

grieving the loss of a loved one too intensely can double the risk of early death

Health News

Ivermectin Proven To Cut Malaria Cases By 26%, Study Finds—Here’s How It Works

ivermectin proven to cut malaria cases by 26%, study finds—here’s how it works

Fitness

Skipping Weekday Workouts? This Diabetes Study Says Its Totally Fine Only 'If You Do This'

you don’t need daily workouts: this diabetes study says that’s totally fine, if you do this

We often hear the older generation claim that youngsters these days, compared to the previous generation, are much weaker. Claims like ‘teenagers from the older generations were much healthier and physically capable’ can be seen on social media, however, does this hold any truth? Have the recent generations grown unhealthier or more fragile? There are two sides to every coin, and this question is the same. A new study by researchers at the Perelman School of Medicine and Children’s Hospital of Philadelphia (CHOP) has found that children's health in the United States is getting worse. 

On the flip side of this coin, we see how and why has the health of children declined in the recent past, is it because kids have grown lazier or does the declining health allude to other factors? 

<h2>How <span rel="noindex">Has Health Declined In Children</span>? </h2>

This decline is seen in several key areas: kids are facing more long-term illnesses, higher rates of both physical and mental health problems, and sadly, even increased death rates compared to children in other wealthy countries. The study also highlights that these are broad, systemic issues, meaning we need new ways to think about supporting and prioritizing children's health. These important findings were published in a medical journal called JAMA. 

<h2>How Do We Know Health Among Children Has Declined? </h2>

Christopher B. Forrest, one of the main authors of the study, said that no single piece of information in their research was shocking on its own. Instead, they gathered a huge amount of data over several years, involving millions of children. All this data consistently pointed to the same worrying trend: an overall decline in the health of children and young people. 

To conduct this study, the researchers used information from five national surveys, government records on deaths, and a large database of children's medical records. They looked at how children's health changed from 2007 to 2023. They examined over 170 different health indicators, including long-term physical, developmental, and mental health conditions, death rates, obesity, difficulties with daily activities, and various physical and emotional symptoms. 

The study revealed some concerning statistics, from 2007 to 2022, the death rate for babies younger than 1 year old was about 1.78 times higher in the U.S. compared to 18 other rich countries. In children between the age of 1 and 19, the death rate was about 1.80 times higher. The biggest differences for babies were due to being born too early and sudden unexpected infant deaths. For older children, the largest gaps were linked to gun violence and car accidents. 

Additionally, from 2011 to 2023, the number of children aged 3 to 17 with a long-term health condition also increased. In one group of 10 children's hospitals, it went from about 40% to 46%. For the general population, it rose from about 26% to 31%. 

Interestingly, during the study period, researchers also saw increases in rates of obesity, girls starting puberty earlier, trouble sleeping, limits on daily activities, various physical symptoms, feelings of sadness, and loneliness. 

<h2>What Does A High Mortality Rate Among Children Signify? </h2>

The researchers emphasize that healthy children are the foundation for a healthy country, as healthy kids are more likely to become healthy adults. They note that recent scientific reviews suggest the U.S. is facing a serious crisis with children's health getting poorer. This has sparked a lot of interest in understanding the main causes of these problems. 

UNICEF notes that we have made significant progress in reducing child mortality rates, which has fallen by 52 per cent. With the help of lifesaving intervention, more and more children are being granted the gift of healthy living, however, the fight hasn’t ended yet. The 2024 United Nations Inter-agency Group for Child Mortality Estimation report that children are still dying from preventable causes. An estimated 4.8 million children died in 2023 before reaching the age of five, this includes children who died within the first 28 days of their life and 2.5 million children within the age of 1-59 months. Beyond this, we saw the death of 2.1 million children, adolescents as well as youngsters aged 5-24. Here are some things that these numbers show 

High child mortality directly reflects unfair access to healthcare, nutrition, and protection, especially in vulnerable areas. Deaths result from these critical inequalities. 

Many child deaths are avoidable, highlighting failures in public health, vaccine access, clean water, and basic medical care. These are not inevitable tragedies. 

High rates show weak national commitments, insufficient health investments, and fragile systems. Sustained success needs strong national effort and robust health data. 

Child mortality reveals deep inequality. Children from poorer families, rural areas, or less educated mothers face higher death risks, especially in certain regions. 

Living in unstable or war-torn regions drastically raises a child's death risk. These areas bear a disproportionate burden, showing violence's devastating toll.

Nearly half of all under-five deaths are newborns, emphasizing their extreme fragility. This demands more targeted interventions and investment during early life. 

Persistent high mortality signals that global child survival gains are threatened. Crises, economic instability, and weak health systems could reverse hard-won progress. 

High child mortality demands immediate action, strong political will, and financial commitment. Every child deserves an equal chance at survival, which must be ensured. 

<h2>Building a Better Future for Our Kids </h2>

While the authors strongly believe we need to identify and address the direct causes of these problems, they also strongly argue for broader solutions. This means we should focus on making a better "home environment" for children. This involves building stronger connections between people, improving the places where kids live, and creating community systems that truly help them. 

We need to spend money on excellent early education for young children, better support for families, safer neighborhoods, and healthcare that understands and respects different cultures. 

Kids are naturally strong and can bounce back. If we make their surroundings better and fix the problems found in this study, we can build a solid base for a healthier future for all young people in our country. 

Childrens Health

Childrens Health declining

Has Health Declined In Children

children mortality rates

why are kids today so unhealthy

worrying declining health of children

We often hear the older generation claim that youngsters these days, compared to the previous generation, are much weaker. Claims like ‘teenagers from the older generations were much healthier and physically capable’ can be seen on social media, however, does this hold any truth? Have the recent generations grown unhealthier or more fragile? There are two sides to every coin, and this question is the same. A new study by researchers at the Perelman School of Medicine and Children’s Hospital of Philadelphia (CHOP) has found that children's health in the United States is getting worse. On the flip side of this coin, we see how and why has the health of children declined in the recent past, is it because kids have grown lazier or does the declining health allude to other factors? How Has Health Declined In Children? This decline is seen in several key areas: kids are facing more long-term illnesses, higher rates of both physical and mental health problems, and sadly, even increased death rates compared to children in other wealthy countries. The study also highlights that these are broad, systemic issues, meaning we need new ways to think about supporting and prioritizing children's health. These important findings were published in a medical journal called JAMA. How Do We Know Health Among Children Has Declined? Christopher B. Forrest, one of the main authors of the study, said that no single piece of information in their research was shocking on its own. Instead, they gathered a huge amount of data over several years, involving millions of children. All this data consistently pointed to the same worrying trend: an overall decline in the health of children and young people. To conduct this study, the researchers used information from five national surveys, government records on deaths, and a large database of children's medical records. They looked at how children's health changed from 2007 to 2023. They examined over 170 different health indicators, including long-term physical, developmental, and mental health conditions, death rates, obesity, difficulties with daily activities, and various physical and emotional symptoms. Worrying Numbers The study revealed some concerning statistics, from 2007 to 2022, the death rate for babies younger than 1 year old was about 1.78 times higher in the U.S. compared to 18 other rich countries. In children between the age of 1 and 19, the death rate was about 1.80 times higher. The biggest differences for babies were due to being born too early and sudden unexpected infant deaths. For older children, the largest gaps were linked to gun violence and car accidents. Additionally, from 2011 to 2023, the number of children aged 3 to 17 with a long-term health condition also increased. In one group of 10 children's hospitals, it went from about 40% to 46%. For the general population, it rose from about 26% to 31%. Interestingly, during the study period, researchers also saw increases in rates of obesity, girls starting puberty earlier, trouble sleeping, limits on daily activities, various physical symptoms, feelings of sadness, and loneliness. What Does A High Mortality Rate Among Children Signify? The researchers emphasize that healthy children are the foundation for a healthy country, as healthy kids are more likely to become healthy adults. They note that recent scientific reviews suggest the U.S. is facing a serious crisis with children's health getting poorer. This has sparked a lot of interest in understanding the main causes of these problems. UNICEF notes that we have made significant progress in reducing child mortality rates, which has fallen by 52 per cent. With the help of lifesaving intervention, more and more children are being granted the gift of healthy living, however, the fight hasn’t ended yet. The 2024 United Nations Inter-agency Group for Child Mortality Estimation report that children are still dying from preventable causes. An estimated 4.8 million children died in 2023 before reaching the age of five, this includes children who died within the first 28 days of their life and 2.5 million children within the age of 1-59 months. Beyond this, we saw the death of 2.1 million children, adolescents as well as youngsters aged 5-24. Here are some things that these numbers show Unequal Access High child mortality directly reflects unfair access to healthcare, nutrition, and protection, especially in vulnerable areas. Deaths result from these critical inequalities. Preventable Deaths Many child deaths are avoidable, highlighting failures in public health, vaccine access, clean water, and basic medical care. These are not inevitable tragedies. Weak Health Systems High rates show weak national commitments, insufficient health investments, and fragile systems. Sustained success needs strong national effort and robust health data. Socio-economic Gaps Child mortality reveals deep inequality. Children from poorer families, rural areas, or less educated mothers face higher death risks, especially in certain regions. Crises & Conflict Impact Living in unstable or war-torn regions drastically raises a child's death risk. These areas bear a disproportionate burden, showing violence's devastating toll. Newborn Vulnerability Nearly half of all under-five deaths are newborns, emphasizing their extreme fragility. This demands more targeted interventions and investment during early life. Progress at Risk Persistent high mortality signals that global child survival gains are threatened. Crises, economic instability, and weak health systems could reverse hard-won progress. Urgent Action Needed High child mortality demands immediate action, strong political will, and financial commitment. Every child deserves an equal chance at survival, which must be ensured. Building a Better Future for Our Kids While the authors strongly believe we need to identify and address the direct causes of these problems, they also strongly argue for broader solutions. This means we should focus on making a better "home environment" for children. This involves building stronger connections between people, improving the places where kids live, and creating community systems that truly help them. We need to spend money on excellent early education for young children, better support for families, safer neighborhoods, and healthcare that understands and respects different cultures. Kids are naturally strong and can bounce back. If we make their surroundings better and fix the problems found in this study, we can build a solid base for a healthier future for all young people in our country.  

children's health has declined significantly in the past decade - what caused this and can it improve?

Why Do Some Cancer Patients Respond Better To Treatment Than Others? The Answer Lies In Our Body’s Defense Mechanism

Why Do Some Cancer Patients Respond Better To Treatment Than Others? The Answer Lies In Our Body’s Natural Defense

What Is Metastatic Cancer? How It Spreads, What It Means And Why Chemotherapy Isn’t Always Enough

what is metastatic cancer? how it spreads, what it means and why chemotherapy isn’t always enough

College Student Beats Breast Cancer By Lifting Through Recovery - How Active Recovery Helped Her Treatment

college student beats breast cancer by lifting through recovery - how active recovery helped her treatment

PTSD In Combat Veterans Could Be Treated With This African Drug - Study Finds

ptsd in combat veterans could be treated with this african drug - study finds

Our bodies work in mysterious ways, even if you see similar results in some people, there will always be exceptions. <span>Cancer treatment</span> is no different. Even though the odds are good for certain people, others cannot be as sure of how or what may happen during the process of treatment but why is that?

Powerful new <span>cancer</span> treatment, called immunotherapy, work incredibly well for some cancers but barely affects others. Now, scientists think they might know why, it turns out that tiny proteins in a patient's own body, called autoantibodies, seem to play a big role in how well these treatments work. These autoantibodies are usually linked to illnesses where the immune system attacks the body, like psoriasis or lupus. But this new research suggests they can also greatly influence a person's response to cancer immunotherapies. 

<h2>How Autoantibodies Influence Tumor Shrinkage?</h2>

The study found that certain natural autoantibodies can significantly increase the chances of tumors shrinking. In some cases, these autoantibodies made it five to ten times more likely for a patient to respond positively to a type of immunotherapy called checkpoint blockade. This is a major discovery because it shows these naturally occurring proteins can have a powerful effect on treatment outcomes. 

This research focused on immune checkpoint inhibitors. These are drugs designed to boost the body's natural ability to fight cancer. They essentially remove the cancer cells' "disguise" that allows them to hide from the immune system. While these drugs have completely changed how we treat many cancers, like melanoma and certain lung cancers, they don't work for everyone. Understanding why some patients respond and others don't has been a big puzzle. 

<h2>Why Do Some People Respond Better To Cancer Treatment? </h2>

According to a 2020 study in the National Cancer Institute, researchers looked at ‘exceptional responders’ meaning people who respond exceptionally well to treatment while others don’t. Many of the patients in this study had advanced cancers that are usually very hard to treat, yet some of them saw their cancer shrink for many years. 

The researchers found that for about a quarter of the patients (26 out of 111), the researchers found specific molecular features in their tumors that could explain their amazing responses. These features included unusual combinations of rare genetic changes in the tumor, or a high number of certain immune cells, like B lymphocytes, getting into the tumor. They also found that some people who had unusual changes in the BRCA1 or BRCA2 genes which are responsible for repairing the DNA, also influenced the treatment. These unusual changes meant the genes couldn’t repair the DNA, making the cancer cells vulnerable to treatment. 

In other cases, the body's immune system played a big role in getting rid of the tumor. For example, higher levels of specific immune cells called B lymphocytes in tumors were linked to these great responses. 

Another interesting find was that sometimes, due to a rare combination of genes, the treatment led to the death of tumor cells, this is called synthetic lethality, meaning that two non-lethal things combine and become a deadly combo. 

<h2>Role of Autoantibodies in Cancer Treatment </h2>

The study revealed that cancer patients generally have more of these autoantibodies in their blood than healthy people. What's fascinating is that some of these autoantibodies were connected to better treatment results. 

For example, certain autoantibodies acted like a shield, blocking a specific immune signal called interferon. When these autoantibodies were present, the immunotherapy drugs, like checkpoint inhibitors, were much more effective at attacking tumors. This makes sense because other research has shown that too much interferon can actually exhaust the immune system, making it less effective at fighting cancer. 

It's almost as if some patients' bodies produced their own helpful medicine, neutralizing interferon and giving the cancer treatment a significant boost. This discovery provides a clear path for creating new combination therapies that could intentionally adjust the interferon pathway for all patients. 

However, not all autoantibodies were helpful. Some were actually linked to worse outcomes. These likely interfered with important immune system functions needed to fight cancer. Future research will focus on finding ways to remove or block these harmful autoantibodies, which could improve immunotherapy for many more patients. 

Cancer

Cancer treatment

factors that affect cancer treatment

Autoantibodies and cancer treatment

tumors shrinkage

how well do cancer treatments work

Our bodies work in mysterious ways, even if you see similar results in some people, there will always be exceptions. Cancer treatment is no different. Even though the odds are good for certain people, others cannot be as sure of how or what may happen during the process of treatment but why is that?Powerful new cancer treatment, called immunotherapy, work incredibly well for some cancers but barely affects others. Now, scientists think they might know why, it turns out that tiny proteins in a patient's own body, called autoantibodies, seem to play a big role in how well these treatments work. These autoantibodies are usually linked to illnesses where the immune system attacks the body, like psoriasis or lupus. But this new research suggests they can also greatly influence a person's response to cancer immunotherapies. How Autoantibodies Influence Tumor Shrinkage?The study found that certain natural autoantibodies can significantly increase the chances of tumors shrinking. In some cases, these autoantibodies made it five to ten times more likely for a patient to respond positively to a type of immunotherapy called checkpoint blockade. This is a major discovery because it shows these naturally occurring proteins can have a powerful effect on treatment outcomes. This research focused on immune checkpoint inhibitors. These are drugs designed to boost the body's natural ability to fight cancer. They essentially remove the cancer cells' "disguise" that allows them to hide from the immune system. While these drugs have completely changed how we treat many cancers, like melanoma and certain lung cancers, they don't work for everyone. Understanding why some patients respond and others don't has been a big puzzle. Why Do Some People Respond Better To Cancer Treatment? According to a 2020 study in the National Cancer Institute, researchers looked at ‘exceptional responders’ meaning people who respond exceptionally well to treatment while others don’t. Many of the patients in this study had advanced cancers that are usually very hard to treat, yet some of them saw their cancer shrink for many years. The researchers found that for about a quarter of the patients (26 out of 111), the researchers found specific molecular features in their tumors that could explain their amazing responses. These features included unusual combinations of rare genetic changes in the tumor, or a high number of certain immune cells, like B lymphocytes, getting into the tumor. They also found that some people who had unusual changes in the BRCA1 or BRCA2 genes which are responsible for repairing the DNA, also influenced the treatment. These unusual changes meant the genes couldn’t repair the DNA, making the cancer cells vulnerable to treatment. In other cases, the body's immune system played a big role in getting rid of the tumor. For example, higher levels of specific immune cells called B lymphocytes in tumors were linked to these great responses. Another interesting find was that sometimes, due to a rare combination of genes, the treatment led to the death of tumor cells, this is called synthetic lethality, meaning that two non-lethal things combine and become a deadly combo. Role of Autoantibodies in Cancer Treatment The study revealed that cancer patients generally have more of these autoantibodies in their blood than healthy people. What's fascinating is that some of these autoantibodies were connected to better treatment results. For example, certain autoantibodies acted like a shield, blocking a specific immune signal called interferon. When these autoantibodies were present, the immunotherapy drugs, like checkpoint inhibitors, were much more effective at attacking tumors. This makes sense because other research has shown that too much interferon can actually exhaust the immune system, making it less effective at fighting cancer. It's almost as if some patients' bodies produced their own helpful medicine, neutralizing interferon and giving the cancer treatment a significant boost. This discovery provides a clear path for creating new combination therapies that could intentionally adjust the interferon pathway for all patients. However, not all autoantibodies were helpful. Some were actually linked to worse outcomes. These likely interfered with important immune system functions needed to fight cancer. Future research will focus on finding ways to remove or block these harmful autoantibodies, which could improve immunotherapy for many more patients. 

Why Do Some Cancer Patients Respond Better To Treatment Than Others? Answer Lies In Body’s Defense Mechanism

why do some cancer patients respond better to treatment than others? the answer lies in our body’s natural defense

Hepatitis Day 2025: Is Hepatitis On A Decline Or Still A Cause Of Concern?

hepatitis day 2025: is hepatitis on a decline or still a cause of concern?

Many cancers can often be treated successfully when detected early. Surgery, radiation and chemotherapy are all powerful tools to remove or destroy tumors in their original location. However, when cancer metastasizes, that is, when the original tumor at one place in the body breaks loose and begins growing elsewhere in the body, the treatment becomes infinitely more complex. This is the stage of metastatic or stage 4 cancer, which forms the true proving ground of modern medicine.

<span>Metastatic cancer</span> happens when cancer cells detach from the primary tumor, circulate in the bloodstream or lymphatic system, and develop new tumors in other tissues or organs. They are not a new type of cancer; they're the same cancer that originally occurred at the primary site.

So if colon cancer metastasizes to the liver, it's still colon cancer—not liver cancer. This makes a difference because it decides how physicians treat the disease. For example, metastatic breast cancer in the lungs is treated with breast cancer therapies, not with lung cancer drugs.

<h2>How Does Cancer Spread from One Organ to Another?</h2>

Metastasis is the biological process that begins when cancer cells become capable of invading nearby tissues. They can enter into the bloodstream or lymph system, catch a ride to other places, and take up residence in new sites. If they are successful, they will start developing new tumors.

Certain cancers follow predictable patterns of metastasis. Prostate cancer tends to spread to bone, and melanoma to brain and lung. Breast cancer prefers lymph nodes, bone, lung, and liver.

Scientists at Memorial Sloan Kettering and other elite centers are trying to figure out why some cancers prefer some organs. Genes, the immune system, and the 'soil' of the target organ (how conducive it is to cancer) all contribute. This may one day be the key to more successful prevention and earlier treatment.

<h2>Where Does Cancer Tend to Spread?</h2>

Although cancer can technically metastasize to nearly any organ in the body, some organs are more frequently involved. The lymph nodes are usually the primary location where cancer cells gain entry, serving as an initial checkpoint for the metastatic process. The liver is a common target, especially in colon, pancreatic, and stomach cancer, because of its high vascular flow and filtering function. Lungs are a frequent location, particularly in cancers originating from the breast, colon, and kidneys. Bones are frequently involved in advanced lung, breast, and prostate cancer, producing pain and architectural disturbances. The brain, on the other hand, is a frequent location of metastasis in melanoma and lung cancer patients with resultant neurological manifestations and special treatment.

The symptoms of metastatic cancer vary greatly depending on where the cancer has spread. For instance:

<ul><li>Bone metastases typically cause deep, aching pain and possibly lead to bone fractures.</li><li>Lung metastases may cause cough, chest discomfort, or shortness of breath.</li><li>Liver metastases can result in belly pain, jaundice, or abnormal liver enzymes in a blood test.</li><li>Brain metastases may trigger headaches, seizures, or neurological changes.</li></ul>Some patients do not have symptoms immediately. Metastasis is often diagnosed through imaging or blood tests done for check-up or unrelated reasons.

This is where it gets complicated. A few forms of metastatic cancer are held to be potentially curable—particularly if the spread is limited and treatment is forceful. A good example is with colorectal cancer that has a small quantity of liver metastases. In these scenarios, surgical resection with chemotherapy could lead to long-term survival.

But most cancers that spread are not curable in the classical sense. That doesn't necessarily leave the patient out of luck. Many treatments try to contain the disease, alleviate symptoms, and buy time. That's called palliative care, but it doesn't mean surrendering—it means redefining success from cure to control.

Others survive for years with stage 4 cancer, particularly with the help of today's therapies such as targeted therapy and immunotherapy. Outcomes are highly variable depending on the cancer type, the degree of metastasis, and the responsiveness of the cancer to treatment.

<h2>Why Chemotherapy May Have Stopped Working For Metastatic Cancer?</h2>

Chemotherapy is still a mainstay of cancer treatment, including metastatic cancer. Chemotherapy kills rapidly dividing cells, a characteristic of cancer. However, cancer cells can become resistant to chemo drugs over time. Such resistance could be driven by genetic mutations, alterations in the tumor microenvironment, or prolonged exposure to the same agent.

Notably, it's not that chemotherapy "stops working" across the board. Rather, it might cease to work for an individual patient's cancer. When this occurs, oncologists will usually change to another drug, use combination therapies, or investigate clinical trials with newer treatments.

As Professor Ian Davis, Director of ANZUP Cancer Trials Group, explained, “We’ve known for more than 20 years that chemotherapy has significant efficacy in metastatic prostate cancer. It hasn’t stopped working—newer agents are simply expanding our arsenal.”

<h2>What Comes Next When Cancer Progresses?</h2>

Living with cancer that is advanced is coping not only with the disease but also with the emotional, physical, and practical issues associated with it. Discussions around prognosis, life quality, and treatment options become the forefront. The following is what patients and families need to remember:

<ul><li>Alternatives are still present, even if a therapy stops working, another can benefit. These include clinical trials, targeted therapies, or symptom-management interventions.</li><li>Support, counseling, support groups, and palliative care services assist patients in coping physically and emotionally.</li><li>Quality of life takes precedence since many individuals opt for treatments that enable them to feel more like they have a sense of normalcy, even though such treatments may not guarantee a cure.</li></ul>

Breakthroughs in genetic testing, liquid biopsies, and tailored medicine are providing physicians with additional tools for comprehending and tackling metastatic disease. Immunotherapies—medications that utilize the body's immune system to combat cancer—are providing long-term remission to some patients who formerly had limited choices.

At the same time, targeted treatments focus specifically on the cancer cells' distinct mutations, minimizing harm to other tissue. For a few types of cancer, such as metastatic lung cancer with particular gene mutations, such targeted medicines have greatly prolonged survival.

Although chemotherapy remains pertinent, the future of cancer treatment is certainly more individualized, targeted, and patient-focused. Although it usually can't be cured, metastatic cancer isn't necessarily a death knell. With the proper treatment team, educated decisions, and emotional support, many patients still discover meaning, happiness, and even renewed vigor as they move through the treatment journey ahead.

metastatic cancer

how cancer spreads

cancer metastasis explained

chemotherapy resistance

Many cancers can often be treated successfully when detected early. Surgery, radiation and chemotherapy are all powerful tools to remove or destroy tumors in their original location. However, when cancer metastasizes, that is, when the original tumor at one place in the body breaks loose and begins growing elsewhere in the body, the treatment becomes infinitely more complex. This is the stage of metastatic or stage 4 cancer, which forms the true proving ground of modern medicine.Metastatic cancer happens when cancer cells detach from the primary tumor, circulate in the bloodstream or lymphatic system, and develop new tumors in other tissues or organs. They are not a new type of cancer; they're the same cancer that originally occurred at the primary site.So if colon cancer metastasizes to the liver, it's still colon cancer—not liver cancer. This makes a difference because it decides how physicians treat the disease. For example, metastatic breast cancer in the lungs is treated with breast cancer therapies, not with lung cancer drugs.How Does Cancer Spread from One Organ to Another?Metastasis is the biological process that begins when cancer cells become capable of invading nearby tissues. They can enter into the bloodstream or lymph system, catch a ride to other places, and take up residence in new sites. If they are successful, they will start developing new tumors.Certain cancers follow predictable patterns of metastasis. Prostate cancer tends to spread to bone, and melanoma to brain and lung. Breast cancer prefers lymph nodes, bone, lung, and liver.Scientists at Memorial Sloan Kettering and other elite centers are trying to figure out why some cancers prefer some organs. Genes, the immune system, and the 'soil' of the target organ (how conducive it is to cancer) all contribute. This may one day be the key to more successful prevention and earlier treatment.Where Does Cancer Tend to Spread?Although cancer can technically metastasize to nearly any organ in the body, some organs are more frequently involved. The lymph nodes are usually the primary location where cancer cells gain entry, serving as an initial checkpoint for the metastatic process. The liver is a common target, especially in colon, pancreatic, and stomach cancer, because of its high vascular flow and filtering function. Lungs are a frequent location, particularly in cancers originating from the breast, colon, and kidneys. Bones are frequently involved in advanced lung, breast, and prostate cancer, producing pain and architectural disturbances. The brain, on the other hand, is a frequent location of metastasis in melanoma and lung cancer patients with resultant neurological manifestations and special treatment.Symptoms Of Metastatic CancerThe symptoms of metastatic cancer vary greatly depending on where the cancer has spread. For instance:Bone metastases typically cause deep, aching pain and possibly lead to bone fractures.Lung metastases may cause cough, chest discomfort, or shortness of breath.Liver metastases can result in belly pain, jaundice, or abnormal liver enzymes in a blood test.Brain metastases may trigger headaches, seizures, or neurological changes.Some patients do not have symptoms immediately. Metastasis is often diagnosed through imaging or blood tests done for check-up or unrelated reasons.Is Metastatic Cancer Curable?This is where it gets complicated. A few forms of metastatic cancer are held to be potentially curable—particularly if the spread is limited and treatment is forceful. A good example is with colorectal cancer that has a small quantity of liver metastases. In these scenarios, surgical resection with chemotherapy could lead to long-term survival.But most cancers that spread are not curable in the classical sense. That doesn't necessarily leave the patient out of luck. Many treatments try to contain the disease, alleviate symptoms, and buy time. That's called palliative care, but it doesn't mean surrendering—it means redefining success from cure to control.Others survive for years with stage 4 cancer, particularly with the help of today's therapies such as targeted therapy and immunotherapy. Outcomes are highly variable depending on the cancer type, the degree of metastasis, and the responsiveness of the cancer to treatment.Why Chemotherapy May Have Stopped Working For Metastatic Cancer?Chemotherapy is still a mainstay of cancer treatment, including metastatic cancer. Chemotherapy kills rapidly dividing cells, a characteristic of cancer. However, cancer cells can become resistant to chemo drugs over time. Such resistance could be driven by genetic mutations, alterations in the tumor microenvironment, or prolonged exposure to the same agent.Notably, it's not that chemotherapy "stops working" across the board. Rather, it might cease to work for an individual patient's cancer. When this occurs, oncologists will usually change to another drug, use combination therapies, or investigate clinical trials with newer treatments.As Professor Ian Davis, Director of ANZUP Cancer Trials Group, explained, “We’ve known for more than 20 years that chemotherapy has significant efficacy in metastatic prostate cancer. It hasn’t stopped working—newer agents are simply expanding our arsenal.”What Comes Next When Cancer Progresses?Living with cancer that is advanced is coping not only with the disease but also with the emotional, physical, and practical issues associated with it. Discussions around prognosis, life quality, and treatment options become the forefront. The following is what patients and families need to remember:Alternatives are still present, even if a therapy stops working, another can benefit. These include clinical trials, targeted therapies, or symptom-management interventions.Support, counseling, support groups, and palliative care services assist patients in coping physically and emotionally.Quality of life takes precedence since many individuals opt for treatments that enable them to feel more like they have a sense of normalcy, even though such treatments may not guarantee a cure.Breakthroughs in genetic testing, liquid biopsies, and tailored medicine are providing physicians with additional tools for comprehending and tackling metastatic disease. Immunotherapies—medications that utilize the body's immune system to combat cancer—are providing long-term remission to some patients who formerly had limited choices.At the same time, targeted treatments focus specifically on the cancer cells' distinct mutations, minimizing harm to other tissue. For a few types of cancer, such as metastatic lung cancer with particular gene mutations, such targeted medicines have greatly prolonged survival.Although chemotherapy remains pertinent, the future of cancer treatment is certainly more individualized, targeted, and patient-focused. Although it usually can't be cured, metastatic cancer isn't necessarily a death knell. With the proper treatment team, educated decisions, and emotional support, many patients still discover meaning, happiness, and even renewed vigor as they move through the treatment journey ahead.

Hepatitis A To E: How Each Virus Affects Your Liver?

Quick Stories

Children's Health Has Declined Significantly In The Past Decade - What Caused This And Can It Improve?

Why Do Some Cancer Patients Respond Better To Treatment Than Others? Answer Lies In Body’s Defense Mechanism

What Is Metastatic Cancer? How It Spreads, What It Means And Why Chemotherapy Isn’t Always Enough

Health Conditions A-Z

Children's Health Has Declined Significantly In The Past Decade - What Caused This And Can It Improve?

Think You Cannot Grow Brain Cells In Adulthood? These 7 Foods Say Otherwise, According to a Harvard Doctor

New Sweat-Sensing Wearable Could Help Monitor And Improve Bipolar Disorder Treatment